Clinical Trial Detail

NCT ID NCT04062266
Title Azacitidine and Venetoclax in Treating Patients With High Risk Acute Myeloid Leukemia in Remission
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center
Indications

acute myeloid leukemia

Therapies

Azacitidine + Venetoclax

Age Groups: senior adult

Additional content available in CKB BOOST